EPISODE · Oct 14, 2017 · 26 MIN
Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery
from The AI in Business Podcast
In this episode, we talk to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm reference. Murali and I discuss the surge of medical information and data in the medical industry, the role of artificial intelligence in developing drugs for treatments to various diseases, and the future of AI in drug discovery. For more in-depth interviews on the business applications of artificial intelligence, find us online at: www.TechEmergence.com
NOW PLAYING
Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m